Adjunctive Therapies for Management of Type 1 Diabetes, An Issue of Endocrinology and Metabolism Clinics of North America
Series: The Clinics: Internal Medicine;
- Publisher's listprice EUR 109.99
-
42 962 Ft (40 916 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 13% (cc. 5 585 Ft off)
- Discounted price 37 377 Ft (35 597 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
42 962 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Health Sciences
- Date of Publication 28 September 2026
- ISBN 9780443474408
- Binding Hardback
- No. of pages pages
- Language English 700
Categories
Long description:
In this issue of Endocrinology and Metabolism Clinics, guest editors Drs. Viral N. Shah and Courtney Ackeifi bring their considerable expertise to the topic of Adjunctive Therapies in Type 1 Diabetes. Top experts discuss the latest developments in adjunctive therapies to improve glycemic control, reduce complications, and enhance quality of life for individuals with type 1 diabetes. By targeting mechanisms beyond insulin deficiency-such as insulin resistance, appetite regulation, and renal protection-adjunctive therapies hold promise for delaying disease progression, reducing insulin requirements, and minimizing adverse effects associated with intensive insulin therapy.
- Contains 14 relevant, practice-oriented topics including beyond insulin: why type 1 diabetes needs more; daily GLP-1Ras in ITD: what we’ve learned and what comes next; SGLT inhibitors for renal protection in T1D; combination of GLP-1RA and SGLT in T1D: why, when, and how; the horizon head: emerging adjunctive therapies for T1D; and more.
- Provides in-depth clinical reviews on adjunctive therapies in type 1 diabetes, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
